Beyond weight and blood sugar management, GLP-1s are being linked to broader systemic benefits: Improved cardiovascular outcomes ( major CV events) Better body composition and muscle-to-fat ratio Neuro- and renal-protective effects under investigation Reduced inflammation (CRP, IL-6) Emerging evidence for bone preservation In performance and longevity medicine, **metabolic optimization extends beyond weight loss it supports bone, muscle, and long-term function.** #MoovHealth #GLP1 #Semaglutide #Tirzepatide #Liraglutide #WeightLoss #MedicalWeightLoss #WeightManagement #RegenerativeMedicine #FunctionalMedicine #BoneHealth #Osteoporosis #LongevityMedicine #PerformanceMedicine #MetabolicHealth #WomensHealth #HormoneTherapy #PreventiveMedicine #EvidenceBasedMedicine #CardiometabolicHealth #BodyComposition #FatLossJourney #HealthyAging #LifestyleMedicine Citation: Chen M, Lyu Y, Zhao J, Han X, Huang T, Yang T, Zhou L et al

For men over 50 with metabolic comorbidities, the cardiovascular and glycemic benefits of GLP-1 treatment may be the most meaningful outcomes, independent of how much weight is lost
Side effects that some people using semaglutide experience include: Gastrointestinal issues, such as nausea, vomiting, diarrhea, constipation, heartburn, burping and stomach pains Less often, the following more serious side effects can also occur: Fatigue Rash and itching Swelling of the legs and hands Vision changes Fainting or dizziness Allergic reactions Higher risk for pancreatitis (inflammation of the pancreas) Hypoglycemia (especially when combined with other diabetes medications) Possible risk of increased heart rate and thyroid tumors, including cancer (a warning required by the FDA) If you experience any of these symptoms, call your doctor right away and get emergency medical treatment if the symptoms become severe
palpate both
[DOI] [PubMed] [Google Scholar] 121.Toscano CM, Filetti FM, Almenara CCP, Fioresi M, Vassallo DV
On Trustpilot, the platform holds a 3.2 rating across 5,940+ reviews , a moderate score that suggests inconsistent patient experiences